ADVANCED ENZYME TECHNOLOGIES
Back to Income Statement
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹624 Cr | ₹541 Cr | ₹529 Cr | ₹502 Cr | ₹444 Cr |
What is the latest Revenue of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹624 Cr |
| Mar2024 | ₹541 Cr |
| Mar2023 | ₹529 Cr |
| Mar2022 | ₹502 Cr |
| Mar2021 | ₹444 Cr |
How is Revenue of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹624 Cr | 15.39 | |
| Mar2024 | ₹541 Cr | 2.13 | |
| Mar2023 | ₹529 Cr | 5.49 | |
| Mar2022 | ₹502 Cr | 13.03 | |
| Mar2021 | ₹444 Cr | - | |
Compare Revenue of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹4,193.8 Cr | 0.1% | -0.2% | 9.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,148.0 Cr | 2.6% | 1.2% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,009.0 Cr | 1.3% | -2.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,779.0 Cr | 1.5% | 0.7% | 37.1% | Stock Analytics | |
| CIPLA | ₹115,772.0 Cr | 6.1% | 2.4% | -5.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,616.0 Cr | 2.6% | -0.4% | -2.1% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | 0.1% |
-0.2% |
9.5% |
| SENSEX | -0.8% |
1.4% |
-6.8% |
You may also like the below Video Courses